Literature DB >> 27931682

Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009-2015.

S Shakoor1, S Tahseen2, K Jabeen3, R Fatima4, F R Malik3, A H Rizvi2, R Hasan3.   

Abstract

OBJECTIVE/
BACKGROUND: Fluoroquinolones (FQs) are important anti-tuberculous drugs for the treatment of multidrug-resistant (MDR) tuberculosis. Resistance to FQs leads to fewer options for treatment of tuberculosis (TB), and infection with such strains may also require longer treatment duration. Trends of resistance in Mycobacterium tuberculosis (MTB) are indicators of MTB-resistance evolution. Drivers of such resistance need to be understood and studied to inform preventive strategies.
METHODS: Here, we present FQ-resistance rates and trends in Pakistan from 2010 to 2015 and compare rates with FQ-consumption data and rates in other community pathogens.
RESULTS: Our results reveal a recent decrease in FQ-resistance rates in MTB, but an increase in resistance for Haemophilus influenzae and Shigella spp. Correlation of FQ resistance with FQ consumption at the population level was weak for MTB, although strong associations were noted for H. influenzae and Shigella spp.
CONCLUSION: We discuss the possible reasons for the decrease in resistance rates in TB, putative drivers of resistance other than volume of FQ consumption, and the possible impact of the National Tuberculosis Programme and drug regulatory activities. Copyright Â
© 2016 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Consumption; Defined daily dose; Fluoroquinolone; Resistance; Selective pressure; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27931682     DOI: 10.1016/j.ijmyco.2016.07.008

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  1 in total

1.  Integrating tuberculosis and antimicrobial resistance control programmes.

Authors:  Rumina Hasan; Sadia Shakoor; Johanna Hanefeld; Mishal Khan
Journal:  Bull World Health Organ       Date:  2018-02-05       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.